Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pivalopril is a new orally active inhibitor of angiotensin-converting enzyme.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 3,490 | 5日内发货 | ||
25 mg | ¥ 10,600 | 6-8周 | ||
50 mg | ¥ 13,800 | 6-8周 | ||
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | Pivalopril is a new orally active inhibitor of angiotensin-converting enzyme. |
体内活性 | Pivalopril is a new compound with a hindered sulfur group that has been compared to Captopril for oral angiotensin-converting enzyme (ACE) inhibition in rats and dogs and antihypertensive activity in rats. Pivalopril (incremental doses of 0.01-1.0 mg/kg, p.o.) produces a dose-related antagonism of AngI pressor effects, in conscious normotensive dogs. The ED50 is 0.17 mg/kg for Pivalopril and 0.06 mg/kg for Captopril. Pivalopril (100 mg/kg per day) decreases mean arterial pressure more effectively than Captopril (100 mg/kg per day). It is concluded that Pivalopril is a potent, orally effective ACE inhibitor and antihypertensive agent. In sodium-deficient, conscious spontaneously hypertensive rats (SHR), Pivalopril (1-100 mg/kg, p.o.) produces a dose-related reduction in mean arterial pressure. Pivalopril (0.03-1.0 mg/kg, orally [p.o.]) produces a dose-related antagonism of angiotensin I (AngI)-induced pressor effects, in separate groups of conscious normotensive rats. The ED50 for Pivalopril and Captopril is 0.1 mg/kg. At equieffective doses, the two compounds have similar durations of action. The potency and duration are similar to those of Captopril. In the sodium-replete SHR, 5 days of oral dosing with [2]. |
别名 | Pivopril, RHC 3659(S) |
分子量 | 329.45 |
分子式 | C16H27NO4S |
CAS No. | 81045-50-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Pivalopril 81045-50-3 Endocrinology/Hormones RAAS RHC3659 RHC-3659 Pivopril RHC 3659 RHC 3659(S) Inhibitor inhibitor inhibit